Russia's commercial drug market grows 17% in Jan-Feb

March 2013
Russia & CIS Business & Financial Newswire;3/29/2013, p1
MOSCOW. March 29 (Interfax) - Russia's commercial market for finished pharmaceutical products grew 17% year-on-year to 72 billion rubles in the first two months of 2013, DSM Group reported.


Related Articles

  • GLONASS predicts 20-fold increase of Russian navigation market by 2020. Interfax // Russia & CIS Business & Financial Newswire;5/22/2013, p1 

    MOSCOW. May 22 (Interfax) - Russia's navigation market for automotive transportation will grow twenty-fold by the year 2020, the president of the non-commercial partnership GLONASS, Alexander Gurko, has said.

  • Russia's Colorectal Cancer Drug Market Projected to Grow to More Than $480 Mln in 2016.  // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1 

    The article focuses on a study by Decision Resources Inc. which found that the colorectal cancer (CRC) drug market in Russia will grow to 487 million U.S. dollars in 2016. The report indicates that changes in medical practice, growing CRC patient population and the launch of novel CRC therapies...

  • Commercial drugs market in Russian down 13.3% in Jan. Interfax // Russia & CIS Business & Financial Newswire;3/ 4/2013, p1 

    MOSCOW. March 4 (Interfax) - The volume of the commercial drugs market in Russia fell 13.3% in January compared to the same period of 2012 and amounted to 35 billion rubles, DSM Group reported.

  • TRUCK SALES. Renschler, Andreas // Overdrive;Dec2007, Vol. 47 Issue 12, p24 

    The article presents a forecast on the market performance of the global commercial vehicle industry. According to Daimler Trucks head Andreas Renschler, the global commercial vehicle industry is expected to grow by 50 percent over the next 10 years. Renschler added that the most significant...

  • Corrections.  // American Rose;Mar/Apr2012, Vol. 41 Issue 8, p13 

    A correction to the article on page 49 of the Jan/Feb issue.

  • Celebrating the Creative Process. Batchelder, Ann // Fiberarts;Jan/Feb89, Vol. 15 Issue 4, p2 

    An introduction to the articles contained in the Jan./Feb. 1989 issue of Fiberarts is presented.

  • Review.  // Campaign;08/29/97, Issue 35, p5 

    Discloses that Nestle Rowntree marketing director Martin Corcoran is moving to Moscow, Russia to become the confectionery company's commercial director in Russia.

  • To Russia with Hoechst.  // Chemical Week;10/23/1996, Vol. 158 Issue 40, p7 

    Reports on the establishment of commercial companies in Russia by Hoechst and its drugs subsidiary Hoechst Marion Roussel.

  • ObamaCare Patients Sicker. Investor's Business Daily // Investors Business Daily;4/10/2014, pA01 

    5 Americans who got coverage via the exchanges used costly specialty drugs more than usual in Jan.-Feb., more evidence that enrollees are older and sicker than initially expected, according to an Express Scripts report. HIV prescriptions were four times as common among enrollees, pain drugs 35%....

  • Do emerging markets provide the answer for the pharmaceutical industry? Martini, Luigi G.; Macrae, Sandy // Pharmaceutical Technology Europe;May2010, Vol. 22 Issue 5, p36 

    The article discusses the benefit of developing drug products for the emerging markets to the pharmaceutical industry. According to the authors, it is important for the western pharmaceutical industry to adjust their strategy to research and development and commercialization in order to achieve...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics